Kairos Pharma, Ltd. Financial Overview
Kairos Pharma, Ltd.'s market cap is currently $15.17M. The company's EPS TTM is $-0.197; its P/E ratio is -2.56; Kairos Pharma, Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.